(Q64127240)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

IL-1ra administration does not improve cardiac function in patients with severe sepsis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

G Slotman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

P A Van Leeuwen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Shelly

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S Nasraway

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

A Tenaillon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J Bander

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

G Friedman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

published in

Journal of Critical Care

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

69-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

The effects of interleukin 1 on myocardial function and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Tumor necrosis factor-alpha induces a biphasic effect on myocardial contractility in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Tumor necrosis factor-alpha causes myocardial depression in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2899%2990016-3

7 January 2021

10.1016/S0883-9441(99)90016-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10382786%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference